Work

VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab

Year: 2009

Type: article

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2009.11.019

Authors: David P. Carbone, J. Stuart Salmon, Dean Billheimer, Heidi Chen, Alan Sandler, Heinrich Roder, Joanna Roder, Maxim Tsypin, Roy S. Herbst, Anne S. Tsao, Hai T. Tran, Thao P. Dang

Institutions: Vanderbilt University Medical Center, University of Utah, Vanderbilt University, SpringWorks Therapeutics (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Vanderbilt University, National Cancer Institute

Awards: G1057049065, G2146954135, Molecular Signatures of Lung Cancer, G7586111583

OpenAlex ID: W2004633979

FWCI: 4.568

Cites: 10

Cited by: 52

Related to: 10